CXCR4 and cancer: Under the hypoxic conditions prevalent in cancer [53], hypoxia-inducible factor (HIF)-1α selectively enhances CXCR4 expression and chemotactic responses to CXCL12—including EOC cells, TAMs, and endothelial cells—thus inducing angiogenesis [54].